This article is more than 5 years old. Information may no longer be current.

Triamcinolone acetonide may treat CME

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

HEIDELBERG, Germany — Intravitreal injection of triamcinolone acetonide was successful in treating long-standing cystoid macular edema caused by central retinal vein occlusion in a patient treated here.

Researchers at the university eye clinic treated a 70-year-old patient who had central retinal vein occlusion in one eye for 2 years and in the other eye for 1.5 years. Both eyes received transconjunctival intravitreal injection of 25 mg of crystalline triamcinolone acetonide, with 10 weeks between injections.

In 4 months of follow-up, visual acuity increased from 0.05 to 0.25 in the right eye. In the left eye, with a follow-up period of 6 weeks, visual acuity improved from 0.125 to 0.25. Fluorescein angiography showed a decrease of fluorescein leakage in the macular area.

The case report is published in Graefe's Archive of Clinical and Experimental Ophthalmology.